Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.05% is 881% above its 5-year average of 0.51%, near the high end of its 5-year range (0.17%–5.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 156.97% above its 12-month average of 1.96%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 5.05%.
DEBT TO ASSETS RATIO
5.05%
DEBT TO ASSETS RATIO AVG TTM
1.96%
DEBT TO ASSETS RATIO AVG 3Y
0.67%
DEBT TO ASSETS RATIO AVG 5Y
0.51%
DEBT TO ASSETS RATIO AVG 10Y
0.66%
DEBT TO ASSETS RATIO AVG 15Y
1.53%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+156.97%
CURRENT VS 3Y AVG
+650.84%
CURRENT VS 5Y AVG
+881.32%
CURRENT VS 10Y AVG
+664.19%
CURRENT VS 15Y AVG
+229.16%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 668 covered companies
CURRENT VS SECTOR MEDIAN
+4945.24%
vs the sector median at left
Citius Pharmaceuticals, Inc.
Market Cap
$14.00M
Debt to Assets Ratio
5.05%
TTM Avg
1.96%
3Y Avg
0.67%
5Y Avg
0.51%
Market Cap
$13.72M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.37M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.37M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.67M
Debt to Assets Ratio
1.94%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.98M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.98M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | $14.00M | 5.05% | 1.96% | 0.67% | 0.51% |
| Passage Bio, Inc. (PASG)vs › | $13.78M | 0.00% | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | 0.00% | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.37M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.37M | 0.34% | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.62M | 0.10% | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.67M | 1.94% | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $12.98M | 0.20% | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.98M | 0.69% | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.94M | 0.04% | N/A | N/A | N/A |
Debt/Assets
5.0%
Debt/Equity
0.11
Current Ratio
0.84
Interest Coverage
-143.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.05% |
| 2026-03-31 | 0.61% |
| 2025-12-31 | 1.30% |
| 2025-09-30 | 1.38% |
| 2025-06-30 | 1.47% |
| 2025-03-31 | 0.77% |
| 2024-12-31 | 0.17% |
| 2024-09-30 | 0.23% |
| 2024-06-30 | 0.33% |
| 2024-03-31 | 0.41% |
| 2023-12-31 | 0.44% |
| 2023-09-30 | 0.46% |
| 2023-06-30 | 0.48% |
| 2023-03-31 | 0.56% |
| 2022-12-31 | 0.56% |
| 2022-09-30 | 0.59% |
| 2022-06-30 | 0.60% |
| 2022-03-31 | 0.60% |
| 2021-12-31 | 0.59% |
| 2021-09-30 | 0.60% |
| 2021-06-30 | 0.72% |
| 2021-03-31 | 0.95% |
| 2020-12-31 | 3.72% |
| 2020-09-30 | 3.09% |
| 2020-06-30 | 3.62% |
| 2020-03-31 | 5.33% |
| 2019-12-31 | 5.19% |
| 2019-09-30 | 0.60% |
| 2019-06-30 | 0.68% |
| 2019-03-31 | 0.71% |
| 2018-12-31 | 0.62% |
| 2018-09-30 | 0.56% |
| 2018-06-30 | 0.73% |
| 2018-03-31 | 0.66% |
| 2017-12-31 | 0.61% |
| 2017-09-30 | 0.71% |
| 2017-06-30 | 25.11% |
| 2017-03-31 | 9.48% |
| 2016-12-31 | 6.95% |
| 2016-09-30 | 3.07% |
| 2016-06-30 | 0.75% |
| 2016-03-31 | 3.12% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 38.52% |
| 2014-03-31 | 44.96% |
| 2013-12-31 | 348.29% |
| 2013-09-30 | 2.97% |
| 2013-06-30 | 192000.00% |
| 2013-03-31 | 42773.02% |
| 2012-12-31 | 17421.21% |
| 2012-09-30 | 12627.41% |
| 2012-06-30 | 19490.06% |
| 2012-03-31 | 159958.82% |
| 2011-12-31 | 9580.09% |
| 2011-09-30 | 8723.11% |
| 2011-06-30 | 20623.08% |
